BioCentury
ARTICLE | Politics, Policy & Law

Senate bill introduced to close Orphan drug ‘loophole’

February 11, 2020 11:18 PM UTC
Updated on Feb 11, 2020 at 11:28 PM UTC

Legislation introduced Tuesday in the Senate seeks to tighten the little-used cost recovery pathway to obtaining Orphan Drug designation in the U.S.

The Fairness in Orphan Drug Exclusivity Act is identical to a bill, H.R. 4712, that was introduced in the U.S. House of Representatives in October (see “House Bill Seeks To Tweak Orphan Drug Act”). ...